$MRNS

Marinus Pharmaceuticals Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$9.48 ▼-3.854%

Delayed Price

VOLUME

88,891

DAY RANGE

-

52 WEEK

5.57 - 11.26

Join Discuss about MRNS with like-minded investors

profile
@dros #droscrew
recently

$SNAP Mar03 10.5 C $LAZR Mar03 10 C $LAZR Mar03 11 C $FTI Apr 17 C $AMRN Apr 2 C $HOOD Mar10 10.5 C $AMD Jul 85 C $MARA Apr 10 C $RIVN Mar 22.5 C $SNAP Mar 11 C $HZNP May 115 C $MRNS Mar 7 C $SHEL Mar 61.5 C $RNW Apr 5 C

47 Replies 7 👍 10 🔥

profile
@dros #droscrew
recently

$SNAP Mar03 10.5 C $LAZR Mar03 10 C $LAZR Mar03 11 C $FTI Apr 17 C $AMRN Apr 2 C $HOOD Mar10 10.5 C $AMD Jul 85 C $MARA Apr 10 C $RIVN Mar 22.5 C $SNAP Mar 11 C $HZNP May 115 C $MRNS Mar 7 C $SHEL Mar 61.5 C $RNW Apr 5 C

63 Replies 6 👍 11 🔥

profile
@dros #droscrew
recently

Steve Cohen buys stake in $MRNS $DAWN - filing

98 Replies 14 👍 7 🔥

profile
@dros #droscrew
recently

$TLRY Nov11 4 C $META Jan 125 C $RIVN Nov 40 C $MRNS Dec 5 C $FXI Jan 25 C $WE Dec 3 C

68 Replies 9 👍 13 🔥

profile
@dros #droscrew
recently

RECAP 11/9 Unusual Calls: $TLRY Nov11 4 C $META Jan 125 C $RIVN Nov 40 C $MRNS Dec 5 C $FXI Jan 25 C $WE Dec 3 C

81 Replies 13 👍 6 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Upside momentum continues with S&P futures edging higher, looking to make it a 9th straight day of gains overall, and the Nasdaq Composite looking at an 11th straight day of advances, with no signs of caution by investors heading into key inflation data today and tomorrow. The producer price index (PPI) for October is expected at 8:30 AM, and the consumer price index (CPI) tomorrow, but still no concerns exhibited in the bond market with the 10-year yield at its lowest level in 2-weeks around 1.45%, while gold prices are steady at $1,829 an ounce. The S&P 500 closed at an all-time high for the eighth consecutive session last night, extending the longest winning streak since 1997, as investors added the impact of $1 trillion in fresh government stimulus. That coupled with removed travel lockdowns, a strong earnings season, and positive vaccine news has boosted stocks over the last month. In Asian markets, The Nikkei Index fell -0.75% to 29.285, the Shanghai Index gained 0.24% to settle at 3,507 and the Hang Seng Index rose 0.2% to 24,813. In Europe, the German DAX is up 45 points to 16,090, while the FTSE 100 rise 0.2% to 7,313. Stocks keep pushing higher, making new all time highs each day the past week for the Dow, Nasdaq, S&P 500 and Russell 2000. Events Calendar for Today 6:00 AM ET NFIB Small Business Optimism Index for Oct 7:45 AM ET ICSC Weekly Retail Sales 8:30 AM ET Producer Price Index MoM for October…est. 0.6% 8:30 AM ET Producer Price Index YoY for Oct…est. 8.7% 8:30 AM ET PPI Ex: Food & Energy MoM for October…est. 0.5% 8:30 AM ET PPI Ex Food & Energy YoY for October…est. 6.8% 8:55 AM ET Johnson/Redbook Weekly Sales 4:30 PM ET API Weekly Inventory Data Earnings Calendar: Earnings Before the Open: AFI, AGEN, APRN, BSY, CAH, CCO, CEVA, CNCE, CORR, CSII, CTG, DRNA, EBIX, ECOM, FSS, HAE, HAIN, HCI, HGV, HRMY, IGT, IIVI, ITCI, KPLT, MIDD, MRNS, MRSN, MSGE, OCGN, OSG, OWL, PLTR, PRPL, PRTY, SEAS, SSTI, STWD, SYY, TGI, VCEL, WHF, WKHS, WNC, WRK, XPEL Earnings After the Close: ACHV, AIRG, ALTO, ARLO, ASH, AVID, AXON, CALA, CCXI, CLPT, CNNE, COIN, CPRX, CPSI, CRIS, DAR, DASH,DNUT, DOCS, DSP, DV, EGAN, ELY, EPAY, EPM, EVBG, FC, FGEN, FLGT, FUBO, G, GO, HCKT, HYLN, ID, INO, KODK, LAW, LGND, LPRO, MCFE, MNKD, MODN, NVTS, OCX, ORGO, PAR, PAY, PAYS, PLUG, POSH, PUBM, PXLW, REI, RNG, RPAY, SAIL, SCSC, SEER, SGMS, SILK, SKIN, TMDX, TWNK, TWOU, U, UPST, VERI, VRM, VZIO, WES, WYNN Other Key Events: Baird 51st Annual Global Industrial Conference, 11/9-11/12 (virtual) Bank America 2021 Banking & Financials Conference, 11/9-11/10 (virtual) Cowen 7th Annual Software Bus Tour, 11/9/110 (virtual) Credit Suisse 30th Annual Healthcare Conference, 11/8-11/11 (virtual) JPMorgan Global Consumer, Retail & Luxury Conference, 11/8-11/11 (virtual) EEI Financial Conference, 11/7-11/9 (virtual) REITWorld 2021 Annual Conference, 11/9-11/12 (virtual) China PPI, CPI and M2 Money Supply for October Sector News Breakdown Consumer AMC Entertainment ($AMC) Q3 EPS ($0.44) vs est. ($0.53) on revenue $763.2M vs est. $708.3M; currently has liquidity availability over $1.8B, does not anticipate the need to borrow under revolver lines over the next 12 months CarLotz ($LOTZ) 3Q EPS ($0.03) vs est. ($0.21) on revs $68Mm vs est. $55.2Mm, will continue to open new hubs in 2022, though fewer than in 2021; says expects sequential qtrly improvement in retail units sold and retail GPU in 4Q Clarus Corp ($CLAR) 3Q adj EPS $0.50 vs est. $0.48 on sales $109Mm vs est. $106.1Mm; guides FY sales $362.5Mm vs est. $359.7Mm Freshpet ($FRPT) shares fell -14%; Q3 EPS (5c) vs est. 7c profit on revenue $107.6M vs est. $115.5M; now sees FY sales approx. $445M from prior guidance of sales exceeding $445M, adj EBITDA approx. $50M from prior view above $61M Hertz ($HTZZ)5M share Secondary priced at $29.00 R. Horton ($DHI) Q4 EPS $3.70 vs. est. $3.40; Q4 revs $8.1B vs. est. $7.94B; consolidated pre-tax profit margin improved 480 basis points to 21.3% and consolidated pre-tax income increased 63% to $1.7B; Q4 net sales orders down 33% to 15,949 homes; sees FY22 revenue $32.5B-$33.5B above consensus $32.22B International Flavors & Fragrances Inc. ($IFF) Q3 EPS $1.47 vs. est. $1.16; Q3 revs $3.07B vs. est. $2.61B; sees FY21 revs $11.55B vs. est. $10B; sees FY21 adjusted operating EBITDA margin 21% Inter Parfums ($IPAR) Q3 EPS $1.20 vs. est. $0.68; Q3 revs $263M vs. est. $262.69M; said our largest brands, notably Montblanc, Jimmy Choo, Coach, GUESS and Lanvin performed exceptionally well in the Q3 turning in gains of 26%, 40%, 98%, 27%, and 37%, respectively, as compared to 2019’s third quarter Jack Henry Associates ($JKHY) 1Q EPS $1.38 vs est. $1.32 on revs $488.1Mm vs est. $489.4Mm; guides FY adj revs $1.87-1.875B vs est. $1.91B, sees FY EPS $4.64-4.73 vs est. $4.59 Masonite ($DOOR) 3Q adj EPS $1.99 vs est. $1.87 on revs $652Mm vs est. $675Mm; guides FY adj EPS $7.95-8.25 vs est. $8.13, sees FY sales +15-17% vs est. +18.6% RealReal ($REAL) Q3 adj EPS ($0.47) vs est. ($0.50) on revenue $119M vs est. $113.3M, adj EBITDA ($31.5M) vs est. ($36M), gross profit per order $94 vs $90 YoY, GMV $368M was +50% vs 2020 and +46% vs 2019, orders 757k (+38% YoY) ThredUp ($TDUP) 3Q EPS ($0.15) vs est. ($0.16) on revs $63.3Mm vs est. $61.8Mm, qtrly active buyers 1.4Mm and orders 1.3Mm (+14% and 28%, respectively); guides 4Q revs $69-71Mm vs est. $62.8Mm Trex Company ($TREX) Q3 EPS $0.64 vs. est. $0.58; Q3 revs $336M vs. est. $325.6M; guides Q4 revs $295M-$305M vs. est. $276.3M; Net income grew 73% to $74M; diluted earnings per share of $0.64, up 73%; EBITDA grew 76% to $108M; EBITDA margin of 32.2% Energy, Industrials and Materials General Electric ($GE) to split into three public companies – GE Aviation, GE Healthcare, and the combined GE Renewable Energy, GE Power, and GE Digital businesses to become three industry-leading, global, investment-grade public companies Advanced Energy Industries, Inc. ($AEIS) Q3 adj EPS $0.89 vs. est. $0.82; Q3 revs $346.1M vs. est. $341.52M; sees Q4 adj EPS 92c plus/minus 25c vs. est. $1.12; sees Q4 revs $355M plus/minus $20M vs. est. $373.09M. Amyris, Inc. ($AMRS) shares fell -25%; 3Q adj EPS ($0.27) vs est. ($0.15) on revs $48Mm vs est. $64.2Mm; sees FY revs $330-370Mm vs est. $391.6Mm; says supply chain challenges impacting near-term performance and growth trajectory Cabot ($CBT) Q4 adj EPS $1.01 vs. est. $1.03; Q4 revs $904M vs. est. $915.01M; Q4 Reinforcement Materials led the way delivering an increase in EBIT of $167 million while Performance Chemicals also recorded strong results; sees FY22 EPS $5.20-$5.60 vs. est. $5.52 Virgin Galactic ($SPCE) Q3 EPS loss (-$0.32) vs. est. loss (-$0.28); Q3 revs $2.6M vs. est. $1.6M; commercial service on track for q4 2022; strong ticket sales at updated pricing of $450,000 per seat; cash position remains strong at approximately $1.0 billion Financials CoreCivic, Inc. ($CXW) Q3 adj FFO/share $0.48, adj EPS $0.28 vs est. $0.18, revenue $471.2M vs est. $467.1M, adj EBITDA $100.9M vs est. $85.3M; is not providing full-year guidance due to uncertainties surrounding the resurgence of Covid-19 caused by the Delta variant and the administration’s executive actions and policies related to immigration and criminal justice, but will provide FY22 guidance in February when reporting 4Q21 results Cohen & Steers, Inc. ($CNS) preliminary assets under management of $101.6 billion as of October 31, 2021, an increase of $4.3 billion from assets under management at September 30, 2021. The increase was due to net inflows of $138 million and market appreciation of $4.4 billion, partially offset by distributions of $203 million. First Advantage ($FA) files to sell 15M shares of common stock for holders Lemonade Inc. ($LMND) will acquire Metromile in an all-stock transaction that implies a fully diluted equity value of approximately $500 million, or just over $200 million net of cash PayPal ($PYPL) Q3 non-GAAP EPS $1.11 vs. est. $1.07; Q3 revs $6.18B vs. est. $6.23B; Q3 total payment volume of $310B, growing 26%, and 24% on an FX-neutral basis; 4.9 billion payment transactions in qtr, up 22%; expects to add about 55Mm NNAs, including about 3 million active accounts from the acquisition of Paidy; 13.3M NNAs added in qtr , bringing total active accounts to 416 million, up 15%; expects FY TPV growth to be in the range of about 33%-34% at current spot rates and about 31%-32% on an FX basis Robinhood ($HOOD) said a third party had obtained access to email addresses of about 5 mln of its customers, while full names for a different group of nearly 2 mln people in an incident, which took place on Nov. 3; said 310 people had more personal information, including names, birth, dates and zip codes compromised, while 10 customers had more extensive account details revealed Third Coast Bancshares ($TCBX)5M share IPO priced at $25.00

117 Replies 10 👍 6 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Wednesday, August 18, 2021 Futures Up/Down % Last Dow -64.00 0.18% 35,195 S&P 500 -2.25 0.06% 4,441 Nasdaq 18.50 0.12% 15,015 U.S. futures are looking mixed ahead of the Fed Minutes, with the Dow and S&P slipping, while the tech heavy Nasdaq Corp looks to rebound after underperformance on Tuesday, as major averages fell by the most in four-weeks. Fed Minutes from the prior FOMC meeting (after 2:00 PM today) may show discussions about tapering monthly bond purchases, or just how divided FOMC officials are on the debate. Yesterday, Fed Chair Jerome Powell said the pandemic is “still casting a shadow on economic activity.” Overnight, Minneapolis Federal Reserve President Neel Kashkari said Tuesday that incoming economic data will drive the central bank’s decision on when to taper its asset purchases, noting that it’s “reasonable” to foresee such a move taking place late this year or early next year. Yesterday, the Nasdaq fell -0.9%, Dow -0.8% and S&P 500 -0.7% ended down on a day that started with pressure from Chinese equities and saw mega caps slide and home improvement names sell off after Home Depot Q2 comp sales mix. Today, rival Lowe’s (LOW) reports a beat across the board while retail giant Target (TGT) beats on the top and bottom line with slightly better comps, though shares slip. The S&P closed above Monday’s intraday low of 4,437 and today’s intraday low successfully tested a support level of 4,423, the prior high. The move comes one day after the S&P 500 had posted a 100% rise off its March 2020 closing low. It has now been 328 calendar days since the benchmark index last ended a decline of more than 5% from a record high. The current 328 calendar-day run since then end of a decline of more than 5% from a record high, is the longest such streak since early 2018. In Asian markets, The Nikkei Index rebounded, rising 161 points to 27,585, the Shanghai Index gained 38 points to 3,485, and the Hang Seng Index climbed 121 points to 25,867. In Europe, the German DAX is down -15 points to 15,900, while the FTSE 100 slides over -20 points to 7,155. Market Closing Prices Yesterday The S&P 500 Index dropped -31.63 points, or 0.71%, to 4,448.08 The Dow Jones Industrial Average fell -282.12 points, or 0.79%, to 35,343.28 The Nasdaq Composite declined -137.58 points, or 0.93%, to 14,656.18 The Russell 2000 Index declined -26.24 points, or 1.19% to 2,177.17 Events Calendar for Today 7:00 AM ET MBA Mortgage Applications Data 8:30 AM ET Housing Starts MoM for July 8:30 AM ET Building Permits MoM for July 10:30 AM ET Weekly DOE Inventory Data Earnings Calendar: Earnings Before the Open: ADI, EAT, HOOD, LITE, LOW, OSIS, PLCE, SMED, TGT, TJX Earnings After the Close: BBWI, CSCO, JBSS, KEYS, NVDA, RRGB, SNPS, SPTN, VSCO Other Key Events: EnerCom Oil & Gas Conference (virtual), 8/15-8/18 Davidson West Coast Bank Tour (virtual), 8/17-8/18 Deutsche bank Transportation Conference (virtual), 8/17-8/18 B Riley Summer Summit, 8/18-8/19 Citigroup Midstream and Energy Infrastructure Conference (virtual), 8/18-8/19 Jefferies Back-to-School Bus Tour, 8/18-8/19 Macro Up/Down Last Nymex 0.57 67.16 Brent 0.70 69.73 Gold 1.70 1,787.90 EUR/USD 0.0007 1.1717 JPY/USD 0.09 109.69 10-Year Note +0.009 1.267% Sector News Breakdown Consumer Target Corp. ($TGT) Q2 EPS $3.64 vs. est. $3.49; Q2 revs $25.16B vs. est. $25.08B; Q2 comp store sales rise +8.9% vs. est. +8.2%; q2 digital comp sales grew 10%; board approved a new, $15B share repurchase program; for 2H2 2021, expects high single digit growth in comp sales, near high end of previous guidance range; now expects FY operating income margin rate will be 8% or higher Lowe’s ($LOW) Q2 EPS $4.25 vs. est. $4.00; Q2 revs $27.6B vs. est. $26.79B; Q2 consolidated comparable sales decreased (-1.6%) vs. est. decline (-2.2%) and U.S. comparable sales decreased (-2.2%) vs. est. (-2.6%); sees FY21 revenue $92B vs. est. $91.53B; sees FY21 comp sales up 30%; sees FY21 capital expenditures $2B; Q2 cost of sales increased 1.4% to $18.26 billion, to bring gross margin down to 33.78% from 34.08% Krispy Kreme ($DNUT) Q2 EPS $0.13 vs. est. $0.14; Q2 revs $349.2M vs. est. $333.36M; qtrly net revenue growth of 43% and organic growth of 23%, up from a 6.7% decline in Q2 of 2020; sees FY organic revenue growth of 10% to 12% and sees FY adjusted Ebitda of $178M-$185M; sees FY21 revenue $1.34B-$1.38B vs. est. $1.34B Jack Henry ($JKHY) 4Q EPS $1.04 vs est. $0.93 on revs $450.3Mm vs est. $445Mm; guides FY22 adj revs $1.866-1.875B vs est. $1.882B, sees FY EPS $4.53-4.60 vs est. $4.52 La-Z-Boy ($LZB) 1Q adj EPS $0.55 vs est. $0.56 on sales $534.8Mm vs est. $485.9Mm, qtrly written comps in company-owned retail segment +22%; adj consolidated op mgn 6.6%; says rapidly escalating commodity and freight costs have not shown signs of abating, did take additional pricing actions during the qtr and imposed a surcharge on pending dealer orders in backlog; says expect margin performance to begin to improve in 2Q and see finishing FY with consolidated adj op mgn at or near dbl-digits America’s Car-Mart ($CART) Q2 EPS $3.57 vs. est. $3.49; Q2 Same store revenue growth 46.7 % and net charge-offs as a percent of average finance receivables 4.3%. Energy, Industrials and Materials The American Petroleum Institute (API) reported that crude inventories fell 1.163M barrels last week and gasoline inventories fell 1.979M barrels Copper prices eased to their lowest in a month after recent weak economic data reinforced demand fears while a looming central bankers conference focuses attention on interest rates; three-month copper on the London Metal Exchange (LME) fell for a third day JinkoSolar Holding ($JKS) supply pact with Wacker Chemie as it will supply JinkoSolar holding unit Jinko solar co. with over 70,000 tons of polysilicon from sept. 2021 to Dec. 2026 Healthcare Agilent Technologies ($A) Q3 EPS $1.10 vs. est. $0.99; Q3 revs $1.59B vs. est. $1.54B; sees Q4 EPS $1.15-$1.18 above est. $1.11; sees Q4 revenue $1.63B-$1.66B above est. $1.61B; raises FY EPS view to $4.28-$4.31 from prior $4.09-$4.14 and ups rev view GlaxoSmithKline ($GSK) receives FDA accelerated approval for Jemperli (dostarlimab-gxly) for adult patients with mismatch repair-deficient (DMMR) recurrent or advanced solid tumors Marinus Pharmaceuticals (MRNS) reports topline Ganaxolone phase 2 open-label results in tuberous sclerosis complex and receives FDA Orphan Drug designation Tilray ($TLRY) announced the acquisition of a majority of outstanding convertible notes of MedMen Enterprises ($MMNFF) held by certain funds Alcon ($ALC) Q2 core EPS $0.56 vs. est. $0.45; Q2 revs $2.1B vs. est. $1.96B; raises FY21 core EPS view to $2.00-$2.10 from $1.85-$1.95 (est. $1.93) and raises FY21 revenue view to $8B-$8.2B from $7.8B-$8B (est. $7.92B) AnaptysBio ($ANAB) announced that the U.S. FDA approved a second indication for GSK’s ($GSK) JEMPERLI for the treatment of adult patients with mismatch repair deficient recurrent or advanced solid tumors Technology, Media & Telecom CDK Global ($CDK) 4Q adj EPS $0.66 vs est. $0.67 on revs $420.1Mm vs est. $427.7Mm; guides FY22 adj EPS $2.70-2.90 vs est. $3.02, sees FY revs $1.78-1.82B vs est. $1.78B Cree Inc. ($CREE) shares fell -4%; 4Q adj EPS ($0.23) vs est. ($0.24) on revs $145.8Mm vs est. $145.2Mm; guides 1Q adj EPS loss $0.21-0.25 vs est. loss $0.23, sees 1Q revs $144-154Mm vs est. $153.4Mm Cree ($CREE) and STMicroelectronics (STM) announced the expansion of an existing multi-year, long-term silicon carbide wafer supply agreement Instructure Holdings (INST) 2Q ($0.17) on revs $93.6Mm; guides 3Q revs $100.4-101.4Mm, sees 3Q adj net income $21.2-22.2Mm; guides FY adj net income $87.2-89.2Mm Weibo ($WB) Q2 EPS $0.79 vs. est. $0.63; Q2 revs $574.47M vs. est. $527.89M; Q2 monthly active users were 566M in June, a net addition of 43M users on a YoY basis; Q2 mobile MAUs represented 94% of MAUs. Average daily active users were 246M in June, a net addition of 16M users yoy; sees Q3 revs up 20%-25% ViacomCBS ($VIAC) upgraded to Overweight from Equal Weight at Wells Fargo with a price target of $60, up from $45 saying the company’s streaming efforts are bearing fruit and have impressed us, so is moving from historical bears to constructive bulls Bottomline Technologies ($EPAY) announces up to $50M stock repurchase plan

53 Replies 6 👍 6 🔥

profile
@viking #StockTraders.NET
recently

alert on $MRNS for 4$

77 Replies 12 👍 13 🔥

JO
@johnwilson941 #LWT Trading
recently

anyone trade $MRNS

146 Replies 12 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

it would be nice to see $4.40's on MRNS

42 Replies 6 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

started short in $MRNS

53 Replies 9 👍 8 🔥

Key Metrics

Market Cap

538.10 M

Beta

1.18

Avg. Volume

282.85 K

Shares Outstanding

54.57 M

Yield

0%

Public Float

0

Next Earnings Date

2024-03-05

Next Dividend Date

Company Information

marinus pharmaceuticals is a clinical stage biopharmaceutical company dedicated to positively impacting the well-being of patients who suffer from epilepsy and neuropsychiatric disorders. the company is in the midst of developing and commercializing ganaxolone which will treat adults and children with epileptic seizures and women with postpartum depression. on june 29, 2017, the company announced that the u.s. food and drug administration (fda) granted orphan drug designation to ganaxolone for the treatment of cdkl5 disorder. cdkl5 disorder is a severe, rare genetic disorder that affects children at an early age and causes difficult-to-control seizures and neuro-developmental impairment. currently, there are no approved therapies for children with cdkl5 disorder. orphan drug designation is granted by the fda office of orphan products development to novel drugs or biologics that treat a rare disease or condition affecting fewer than 200,000 patients in the u.s. the designation provides

Website:

HQ: ,

Related News